In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal Conditions
- PMID: 34496737
- DOI: 10.2174/1871530321666210908124848
In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal Conditions
Abstract
Background: Hypercholesterolemia is one of the principal causes of the development of cardiovascular diseases. Recently, probiotics consumption has also been proposed as a non-pharmacological intervention to control cholesterol concentrations.
Objective: To evaluate in vitro assimilation of cholesterol by Bifidobacterium animalis subsp. lactis (BPL1) under simulated intestinal environment in anaerobic conditions and to review and discuss potential physiological mechanisms in this context.
Methods: Bacterial viability and cholesterol assimilation were evaluated in both standard MRS and Stimulated Intestinal Fluid (SIF) medium under anaerobic conditions and in the presence or absence of cholesterol. For assimilation assays, cholesterol concentrations in the different suspensions, containing the probiotic or not, were determined by chromatography coupled to mass spectrometry.
Results: The results showed that the growth of B. lactis BPL1 under intestinal conditions is favored when cholesterol is present in the culture medium. In addition, cholesterol assimilation of up to 44.4% under intestinal and anaerobic conditions was observed.
Conclusion: Taking into account the revised literature and the experimental results presented herein, the administration of functional foodstuffs together with probiotic bacteria, such as B. lactis BPL1, could be a potentially effective option to decrease hypercholesterolemia, thus preventing the development of cardiovascular diseases. Nevertheless, further studies on mechanisms of effectiveness in animals and clinical trials are still needed.
Keywords: Bifidobacterium animalis subsp. lactis; SIF; anaerobiosis; cholesterol; functional foodstuffs; probiotic.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway.Microb Biotechnol. 2022 Mar;15(3):805-816. doi: 10.1111/1751-7915.13769. Epub 2021 Feb 23. Microb Biotechnol. 2022. PMID: 33620143 Free PMC article.
-
Characterization of a Bifidobacterium animalis subsp. lactis reference strain based on ecology and transcriptomics.Appl Environ Microbiol. 2024 Oct 23;90(10):e0108024. doi: 10.1128/aem.01080-24. Epub 2024 Sep 5. Appl Environ Microbiol. 2024. PMID: 39235395 Free PMC article.
-
Honey Varietals Differentially Impact Bifidobacterium animalis ssp. lactis Survivability in Yogurt through Simulated In Vitro Digestion.J Nutr. 2024 Mar;154(3):866-874. doi: 10.1016/j.tjnut.2024.01.010. Epub 2024 Jan 12. J Nutr. 2024. PMID: 38219862 Free PMC article.
-
Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases.Int J Mol Sci. 2022 Aug 19;23(16):9334. doi: 10.3390/ijms23169334. Int J Mol Sci. 2022. PMID: 36012597 Free PMC article. Review.
-
Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review.Front Nutr. 2021 Dec 14;8:790561. doi: 10.3389/fnut.2021.790561. eCollection 2021. Front Nutr. 2021. PMID: 34970580 Free PMC article. Review.
Cited by
-
Evaluation of the Probiotic Properties of Lacticaseibacillus casei 431® Isolated from Food for Special Medical Purposes§.Food Technol Biotechnol. 2023 Dec;61(4):418-429. doi: 10.17113/ftb.61.04.23.8045. Food Technol Biotechnol. 2023. PMID: 38205053 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical